Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects
Crossref DOI link: https://doi.org/10.1007/s12325-020-01327-9
Published Online: 2020-04-16
Published Print: 2020-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kankam, Martin
Griffin, Rhonda
Price, Jeffrey
Michaud, Josée
Liang, Wei
Llorens, Mariona Bassas
Sanz, Ana
Vince, Bradley
Vilardell, David
Text and Data Mining valid from 2020-04-16
Version of Record valid from 2020-04-16
Article History
Received: 17 January 2020
First Online: 16 April 2020